Grants and Contracts per year
Fingerprint
Dive into the research topics where Rachael Morgan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
Grants and Contracts
- 3 Finished
-
Pediatric Molecular Tumor Board C3358: FY 23
Villano, J., Badgett, J., Durbin, E. B., Kolesar, J., Lightner, D., Lukins, D., Mirza, F., Morgan, R. & Shelton, B.
KY Cabinet for Health and Family Services
7/1/22 → 6/30/23
Project: Research project
-
Pediatric Molecular Tumor Board C2448: CL 2: FY22 Pediatric Molecular Tumor Board
Villano, J., Badgett, J., Durbin, E. B., Jeong, J. C., Kolesar, J., Lightner, D., Lukins, D., Miller, B., Morgan, R., Morgan, R., Neltner, J., Shelton, B. & Vela, C.
KY Cabinet for Health and Family Services
7/1/20 → 6/30/22
Project: Research project
-
Pediatric Molecular Tumor Board C2448: CL 1: FY21 Pediatric Molecular Tumor Board
Villano, J., Badgett, J., Durbin, E. B., Jeong, J. C., Kolesar, J., Lightner, D., Lukins, D., Miller, B., Morgan, R., Morgan, R., Neltner, J., Shelton, B. & Vela, C.
KY Cabinet for Health and Family Services
7/1/20 → 6/30/21
Project: Research project
Research output
- 4 Article
-
Hematological adverse events in the management of glioblastoma
Garcia, C. R., Myint, Z. W., Jayswal, R., Wang, C., Morgan, R. M., Butts, A. R., Weiss, H. L. & Villano, J. L., Jan 2022, In: Journal of Neuro-Oncology. 156, 1, p. 153-161 9 p.Research output: Contribution to journal › Article › peer-review
-
Dose-dense temozolomide for recurrent high-grade gliomas: a single-center retrospective study
Garcia, C. R., Slone, S. A., Morgan, R. M., Gruber, L., Kumar, S. S., Lightner, D. D. & Villano, J. L., Aug 28 2018, In: Medical Oncology and Tumor Pharmacotherapy. 35, 10, p. 136Research output: Contribution to journal › Article › peer-review
-
EML4-ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib
Huang, T., Engelmann, B. J., Morgan, R. M., Absher, K. J., Kolesar, J. M. & Villano, J. L., May 2018, In: Cancer Chemotherapy and Pharmacology. 81, 5, p. 965-968 4 p.Research output: Contribution to journal › Article › peer-review
-
Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials-impact of psychogenic non-epileptic seizures
Morrow, A. M., Morgan, R. M. & Villano, J. L., Jul 1 2017, In: Neuro-Oncology. 19, 7, p. 1010-1011 2 p.Research output: Contribution to journal › Article